Press Releases

Looking to provide more effective relief for patients while also reducing the need for opioid painkillers, a team from Roswell Park Comprehensive Cancer Center explored whether gabapentin, a drug used to relieve nerve pain and treat seizures, could be an effective alternative to narcotics in managing treatment-related symptoms for these patients. Their results, published in the journal Cancer, show that gabapentin is an effective alternative to standard pain-control drugs.

Providing another view into the center’s high standards of care, Roswell Park Comprehensive Cancer Center has earned full accreditation from the Commission on Cancer (CoC), a quality program of the American College of Surgeons. The hospital has been reaccredited for three years.

Today, Ride for Roswell, presented by the West Herr Automotive Group, launched registration for this summer’s 25th anniversary event, taking place on Saturday, June 27. Online registration is available at RideforRoswell.org.

In a phase III randomized clinical trial, patients with prostate cancer assigned to eat seven or more servings of vegetables and fruits daily saw no extra protection from the increased consumption of micronutrients.

Promoting quality care for our patients and encouraging scientific innovation, Lijian Cai, PharmD, has joined the staff at Roswell Park Comprehensive Cancer Center as Senior Executive Director/Chief Pharmacy Officer.

In 2013, researchers from Roswell Park Comprehensive Cancer Center became one of the first teams to report that chronic stress can encourage the development and proliferation of tumor cells by suppressing natural immunity against cancer. In a new study published in the Journal of Clinical Investigation, the same laboratory has revealed an important and previously unknown means through which chronic stress weakens immunity against cancer

As Roswell Park Comprehensive Cancer Center continues to utilize the latest immunotherapies that spell hope for so many of our patients, BlueCross BlueShield of Western New York has recognized us as a Blue Distinction Center for Cellular Immunotherapy — CAR-T (chimeric antigen receptor). The center is one of two to receive this distinction in New York State.

Generous donations have set in motion eight groundbreaking new research projects at Roswell Park Comprehensive Cancer Center. The promising preliminary studies received a total of $772,330 from the Roswell Park Alliance Foundation, the 501(c)(3) not-for-profit organization that raises funds and manages all donations made to Roswell Park.